Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Apple
AAPL
|
$564M |
| 2 |
UnitedHealth
UNH
|
$439M |
| 3 |
Johnson & Johnson
JNJ
|
$353M |
| 4 |
Amazon
AMZN
|
$200M |
| 5 |
Microsoft
MSFT
|
$198M |
Top Sells
| 1 |
EXE
Expand Energy Corporation Common Stock
EXE
|
$344M |
| 2 |
JPMorgan Chase
JPM
|
$293M |
| 3 |
Kellanova
K
|
$165M |
| 4 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
$159M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
$156M |
Sector Composition
| 1 | Technology | 18.85% |
| 2 | Financials | 18.69% |
| 3 | Industrials | 11.95% |
| 4 | Healthcare | 10.42% |
| 5 | Consumer Discretionary | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRG
3201
Seritage Growth Properties
SRG
$211M
| $103K | ﹤0.01% |
31,937
-5,801
| -15% | -$18.8K |
|
3202
Medallion Financial
MFIN
$249M
| $99.7K | ﹤0.01% |
11,451
| – | – |
|
3203
Vicarious Surgical
RBOT
$33.9M
| $99.3K | ﹤0.01% |
+15,135
| New | +$99.3K |
|
3204
iBio
IBIO
$16.4M
| $97.1K | ﹤0.01% |
24,150
| – | – |
|
3205
MediciNova
MNOV
$63.3M
| $96.7K | ﹤0.01% |
66,215
| – | – |
|
3206
RAVE Restaurant Group
RAVE
$48.6M
| $96.6K | ﹤0.01% |
35,113
+4,664
| +15% | +$12.8K |
|
3207
Backblaze
BLZE
$491M
| $96.1K | ﹤0.01% |
19,905
| – | – |
|
3208
IZEA Worldwide
IZEA
$60.7M
| $93.7K | ﹤0.01% |
44,619
+508
| +1% | +$1.07K |
|
3209
Creative Realities
CREX
$24.6M
| $93.2K | ﹤0.01% |
47,798
-7,150
| -13% | -$13.9K |
|
3210
Aligos Therapeutics
ALGS
$78.8M
| $92.5K | ﹤0.01% |
+11,216
| New | +$92.5K |
|
|
LAC
3211
Lithium Americas
LAC
$698M
| $92.1K | ﹤0.01% |
+34,000
| New | +$92.1K |
|
3212
Acrivon Therapeutics
ACRV
$41.8M
| $90K | ﹤0.01% |
44,154
+7,091
| +19% | +$14.5K |
|
3213
HilleVax
HLVX
$105M
| $89.6K | ﹤0.01% |
61,542
-405
| -0.7% | -$589 |
|
|
ICAD
3214
DELISTED
iCAD Inc
ICAD
| $88K | ﹤0.01% |
42,631
| – | – |
|
3215
RAPT Therapeutics
RAPT
$214M
| $87.3K | ﹤0.01% |
8,944
-9,659
| -52% | -$94.3K |
|
3216
Barnwell Industries
BRN
$11.5M
| $87K | ﹤0.01% |
53,704
-2,009
| -4% | -$3.26K |
|
3217
Precigen
PGEN
$1.3B
| $85.4K | ﹤0.01% |
57,082
| – | – |
|
3218
KORU Medical Systems
KRMD
$188M
| $84.2K | ﹤0.01% |
33,161
-3,039
| -8% | -$7.72K |
|
3219
BRF SA
BRFS
$5.86B
| $83.6K | ﹤0.01% |
24,309
+4,213
| +21% | +$14.5K |
|
3220
SOPHiA GENETICS
SOPH
$219M
| $83.3K | ﹤0.01% |
25,127
+3,508
| +16% | +$11.6K |
|
3221
Sagimet Biosciences
SGMT
$231M
| $82.7K | ﹤0.01% |
25,334
| – | – |
|
3222
Werewolf Therapeutics
HOWL
$61.7M
| $82.4K | ﹤0.01% |
84,607
-110,139
| -57% | -$107K |
|
3223
One Stop Systems
OSS
$126M
| $81K | ﹤0.01% |
34,894
+7,539
| +28% | +$17.5K |
|
|
IMMP
3224
Immutep
IMMP
$242M
| $80.1K | ﹤0.01% |
45,489
| – | – |
|
3225
Intellicheck
IDN
$107M
| $80K | ﹤0.01% |
26,412
+4,627
| +21% | +$14K |
|